206 Ortho was issued a U.S. patent covering a new bio-inspired composite and implants that could fix broken bones without the need for implant removal.Â
Smith & Nephew issued an Urgent Field Safety Notice affecting certain first-generation JOURNEY BCSÂ components due to a higher than expected revision rate.Â
Results from an efficacy study of ReVivo Medical's spinal fusion technology demonstrated that loadsharing through elastic micro-motion accelerates bone formation and interbody fusion.
Bioventus entered into a definitive agreement to divest its next-gen bone morphogenetic protein development program to Viscogliosi Brothers. The transaction is slated to close in 3Q18.
Revo Health and Medtronic entered into a strategic partnership to deliver patient-payment models and enhance outcomes. Medtronic has also made a minority investment in Revo.
Our site uses cookies to allow easier access for Members and subscribers and to improve our site. You agree to our use of cookies by closing this message box or continuing to use our site.OkRead more